ALKBH2 and colorectal carcinoma: ABH2 downregulation inhibits epithelial–mesenchymal transition [53], and a similar regulatory effect was demonstrated in colorectal cancer (CRC) cell lines, where ABH2 knockdown inhibited proliferation and invasive capacity of CRC cells [55].